Barriers to entry in the Canadian pharmaceutical industry: Comments, clarification and extensions
- 31 March 1987
- journal article
- Published by Elsevier in Journal of Health Economics
- Vol. 6 (1) , 59-72
- https://doi.org/10.1016/0167-6296(87)90031-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The importance of being firstInternational Journal of Industrial Organization, 1986
- Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industryJournal of Health Economics, 1985
- Post-patent barriers to entry in the pharmaceutical industryJournal of Health Economics, 1985
- The advantage of being first and competition between firmsInternational Journal of Industrial Organization, 1983
- The Effects of Competition on Prescription-Drug–Product SubstitutionNew England Journal of Medicine, 1983
- The Impact of the PARCOST Program on Prescription Drug Prices in Ontario: Some QueriesCanadian Public Policy, 1982
- The effect of patent expiration on the market position of drugsManagerial and Decision Economics, 1981